The company
INmune Bio Inc.
INMB · Nasdaq
INMB stood above a rising 150-day average in 12 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 7.1% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Just dropped out
- Weeks in an uptrend
- out for 1
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 78 (+0)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 12 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 706,424$1.2M | +19,409+2.8% |
| AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026 | 662,218$1.1M | +391,901+145.0% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 311,613$508K | -882,499−73.9% |
| RAYMOND JAMES FINANCIAL INCadded · filed 14 Aug 2026 | 212,995$347K | +9,750+4.8% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 190,215$310K | -304,754−61.6% |
| GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026 | 185,245$302K | -46,341−20.0% |
| MILLENNIUM MANAGEMENT LLCnew · filed 14 Aug 2026 | 159,559$260K | +159,559 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPreduced · filed 14 Aug 2026 | 158,452$258K | -35,939−18.5% |
| JANE STREET GROUP, LLCadded · filed 14 Aug 2026 | 134,232$219K | +83,288+163.5% |
| UBS Group AGreduced · filed 13 Aug 2026 | 110,413$180K | -142,927−56.4% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.